A macular disease update for eye health professionals
Thanks for reading the latest edition of Macula Matters, MDFA’s e-newsletter for healthcare professionals.
In this edition, you’ll find CPD webinars, updates on the latest macular disease research, and updates on MDFA’s work – including a survey to help us work together to support patients.
MDFA would like to invite you to attend this panel discussion of diabetic eye disease case studies featuring ophthalmologists Dr Peter van Wijngaarden, Dr Amy Cohn and Dr David Fabinyi.
‘Clinical pearls in diabetic retinopathy, from diagnosis to management: a case-based webinar’ is Optometry Australia Quality Assured for one hour of learning.
Upon completion of this CPD activity, participants will understand:
• Clinical risk factors and diabetic retinopathy severity grading
• The role of imaging in the diagnosis of diabetic retinopathy and in guiding management decisions
• The management of diabetic retinopathy, including the role of risk factor control, laser, intravitreal injections and surgical treatment
Join this free CPD webinar on Monday 22 November at 6.30pm AEDT.
MDFA launching free CPD for orthoptists
Orthoptists can soon take MDFA’s new CPD courses on age-related macular degeneration and diabetic eye disease. Launching in December, these two Government-funded courses have been developed with Australia’s leading retinal specialists, including world-renowned ophthalmologist Professor Paul Mitchell AO. As well as these new courses for orthoptists, MDFA also offers free CPD for optometrists, available today through our website.
Check My Macula: 100,000 take the quiz
One year after the launch of Check My Macula – an online tool to raise awareness of the risk factors for macular disease and drive people to their optometrist for an eye exam – more than 100,000 Australians have taken the quiz. Check My Macula has also led to 12,000 resource downloads and more than 2000 people searching for an optometrist near them to book an eye examination – including a check of the macula.
Webinar catch-up: AMD classification, AREDS, management
Presented by A/Prof Alex Hunyor, MDFA Board member and Medical Committee Chair, this CPD webinar examines AMD classification, results, AREDS studies, referral guidelines and implications for clinical practice.
Take our healthcare professional engagement survey
Macular disease treatment: Recent developments
In recent months, a number of developments have taken place in the busy field of macular disease drug development.
Potential treatment for atrophic AMD on the horizon
This September, Apellis announced results from two phase III trials that showed pegcetacoplan slowed GA progression.
Does MDFA offer peer support services?
Living with macular disease can be isolating. MDFA’s peer support might be the answer. As well as the help and support you provide, your patients might also benefit from speaking to people who are going through the same thing they are.
Why should you refer your patients to MDFA?
You work hard to provide important clinical assessment, care and referral. Our job is to provide immediate and lifelong information and support to patients, their families and carers, on every step of their journey with macular disease.
Posted: 17 November 2021